Literature DB >> 12170562

[Glanders--a potential disease for biological warfare in humans and animals].

Ofer Lehavi1, Orna Aizenstien, Lior H Katz, Ariel Hourvitz.   

Abstract

Infection with Burkholderia mallei (formerly Pseudomonas mallei) can cause a subcutaneous infection known as "farcy" or can disseminate to condition known as Glanders. It is primarily a disease affecting horses, donkeys and mules. In humans, Glanders can produce four types of disease: localized form, pulmonary form, septicemia, and chronic form. Necrosis of the tracheobronchial tree and pustular skin lesions characterize acute infection with B. mallei. Other symptoms include febrile pneumonia, if the organism was inhaled, or signs of sepsis and multiple abscesses, if the skin was the port of entry. Glanders is endemic in Africa, Asia, the Middle East, and Central and South America. Glanders has low contiguous potential, but because of the efficacy of aerosolized dissemination and the lethal nature of the disease, B. mallei was considered a candidate for biological warfare. During World War I, Glanders was believed to have been spread to infect large numbers of Russian horses and mules on the Eastern front. The Japanese infected horses, civilians and prisoners of war during World War II. The USA and the Soviet Union have shown interest in B. mallei in their biological warfare program. The treatment is empiric and includes mono or poly-therapy with Ceftazidime, Sulfadiazine, Trimethoprim + Sulfamethoxazol, Gentamicin, Imipenem etc. Aggressive control measures essentially eliminated Glanders from the west. However, with the resurgent concern about biological warfare, B. mallei is now being studied in a few laboratories worldwide. This review provides an overview of the disease and presents the only case reported in the western world since 1949.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170562

Source DB:  PubMed          Journal:  Harefuah        ISSN: 0017-7768


  14 in total

1.  Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Shawn M Zimmerman; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

2.  Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders.

Authors:  Shawn M Zimmerman; Mackenzie E Long; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Vet Pathol       Date:  2017-11-16       Impact factor: 2.221

3.  Present and future therapeutic strategies for melioidosis and glanders.

Authors:  D Mark Estes; Steven W Dow; Herbert P Schweizer; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

4.  Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge.

Authors:  Sylvia R Treviño; Amy R Permenter; Marilyn J England; Narayanan Parthasarathy; Paul H Gibbs; David M Waag; Tran C Chanh
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

5.  An allelic exchange system for compliant genetic manipulation of the select agents Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Mohamad A Hamad; Sheryl L Zajdowicz; Randall K Holmes; Martin I Voskuil
Journal:  Gene       Date:  2008-10-28       Impact factor: 3.688

6.  Burkholderia mallei tssM encodes a putative deubiquitinase that is secreted and expressed inside infected RAW 264.7 murine macrophages.

Authors:  John Shanks; Mary N Burtnick; Paul J Brett; David M Waag; Kevin B Spurgers; Wilson J Ribot; Mark A Schell; Rekha G Panchal; Frank C Gherardini; Keith D Wilkinson; David Deshazer
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

7.  Use of the common marmoset to study Burkholderia mallei infection.

Authors:  Tomislav Jelesijevic; Shawn M Zimmerman; Stephen B Harvey; Daniel G Mead; Teresa L Shaffer; D Mark Estes; Frank Michel; Frederick D Quinn; Robert J Hogan; Eric R Lafontaine
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

8.  Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection.

Authors:  Shane Massey; Linsey A Yeager; Carla A Blumentritt; Sudhamathi Vijayakumar; Elena Sbrana; Johnny W Peterson; Trevor Brasel; James W LeDuc; Janice J Endsley; Alfredo G Torres
Journal:  Sci Rep       Date:  2014-03-07       Impact factor: 4.379

9.  Inactivation of [Fe-S] metalloproteins mediates nitric oxide-dependent killing of Burkholderia mallei.

Authors:  Jessica Jones-Carson; James Laughlin; Mohammed A Hamad; Amanda L Stewart; Martin I Voskuil; Andrés Vázquez-Torres
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

10.  Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.

Authors:  Eric R Lafontaine; Shawn M Zimmerman; Teresa L Shaffer; Frank Michel; Xiudan Gao; Robert J Hogan
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.